Nasdaq Eldn News Today

HC Wainwright restated their buy rating on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) in a research note released on Friday morning, Benzinga reports. HC Wainwright currently has a $13.00 price objective on the stock. Eledon Pharmaceuticals Stock Performance Shares of NASDAQ ELDN opened at $2.07 on Friday. The firm’s 50-day simple moving average […]

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2024 earnings estimates for shares of Eledon Pharmaceuticals in a research report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.33) per share for the quarter. The consensus estimate for Eledon […]

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 65,300 shares, a growth of 147.3% from the November 30th total of 26,400 shares. Based on an average daily volume of 97,400 shares, […]

Eledon Pharmaceuticals (NASDAQ:ELDN – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report released on Monday, Benzinga reports. They currently have a $13.00 target price on the stock. Several other brokerages have also weighed in on ELDN. Noble Financial initiated coverage on shares of Eledon Pharmaceuticals in a report […]

Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) had its target price cut by HC Wainwright from $25.00 to $13.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.31) EPS. A number of other research firms […]

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) saw a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 36,300 shares, a decrease of 85.1% from the June 15th total of 244,200 shares. Based on an average daily trading volume, of 198,000 shares, the days-to-cover […]

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) – HC Wainwright issued their Q2 2023 EPS estimates for Eledon Pharmaceuticals in a research report issued to clients and investors on Friday, May 26th. HC Wainwright analyst V. Bernardino anticipates that the company will earn ($0.47) per share for the quarter. The consensus estimate for Eledon Pharmaceuticals’ […]

Cantor Fitzgerald reissued their overweight rating on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Get Rating) in a report published on Monday morning, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.83) EPS. Eledon Pharmaceuticals Stock Down 0.4 % Shares of NASDAQ:ELDN opened at $2.24 on Monday. The stock has a […]

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 57,200 shares, a growth of 276.3% from the April 15th total of 15,200 shares. Currently, 0.4% of the shares of the company are sold short. Based on […]